- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00846924
30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event (EMBRACE)
30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event: A Randomized Controlled Trial
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada
- Foothills Medical Centre
-
Edmonton, Alberta, Canada
- Grey Nuns Hospital
-
Edmonton, Alberta, Canada
- Walter C. Mackenzie Health Sciences Centre
-
-
British Columbia
-
Vancouver, British Columbia, Canada
- Vancouver Hospital and Health Sciences Centre
-
Victoria, British Columbia, Canada
- Vancouver Island Health Research Centre (VIHA)
-
-
Ontario
-
Hamilton, Ontario, Canada
- Hamilton Health Sciences Centre
-
Kingston, Ontario, Canada
- Kingston General Hospital
-
London, Ontario, Canada
- London Health Sciences Centre
-
London, Ontario, Canada
- Robarts Research Institute
-
Ottawa, Ontario, Canada
- Ottawa Hospital Research Institute -The Ottawa Hospital
-
Thunder Bay, Ontario, Canada
- Thunder Bay Regional HSC
-
Toronto, Ontario, Canada
- St. Michael's Hospital
-
Toronto, Ontario, Canada
- Sunnybrook Health Sciences Centre
-
Toronto, Ontario, Canada
- UHN / Toronto Western Hospital
-
Toronto, Ontario, Canada
- York Central Hospital
-
-
Quebec
-
Montreal, Quebec, Canada
- Montreal General Hospital
-
Quebec City, Quebec, Canada
- CHA-Hôpital de l'Enfant-Jesus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion:
Diagnosis of the index event* made by a stroke specialist of an acute ischemic stroke or TIA (WHO definition) of undetermined etiology (cryptogenic) occurring within the previous 6 months (180 days).The event must be either:
- an embolic arterial ischemic stroke confirmed by neuroimaging; or
- a transient ischemic attack, defined as involving a focal unilateral motor deficit, speech/language deficit, or hemianopia, with symptom duration <24 hours (note: amaurosis fugax/transient monocular blindness, pure sensory spells, isolated vertigo spells, etc. do not qualify for enrolment given the potential for misdiagnosis of such events).
Patient meets the following:
- At least one 12-lead ECG has already been obtained as part of the routine clinical post-stroke/TIA work-up, and no ECGs have shown any episodes of atrial fibrillation or atrial flutter, and;
- A Holter monitor has already been obtained as part of the routine clinical post-stroke/TIA work-up, and does not show any episodes of atrial fibrillation or atrial flutter ≥30 seconds.
- The patient is being actively investigated for the etiology of the stroke/TIA event and additional cardiac monitoring is desired to screen further for the possibility of occult paroxysmal atrial fibrillation/flutter, i.e. patients selected for this study are those for whom the investigator, in his/her clinical judgment, would consider ordering a repeat Holter monitor as part of clinical care.
The following diagnostic tests have already been completed as part of clinical routine post-stroke/TIA:
- brain imaging with CT or MRI,
- vascular imaging of the extracranial and intracranial circulation with either CT angiography or MR angiography to exclude significant large vessel occlusive disease as the most likely mechanism for the index ischemic event (carotid Doppler ultrasound is acceptable for those presenting with anterior circulation ischemic events),
- transthoracic (or transesophageal) echocardiography to exclude thrombus or other structural heart disease that in the opinion of the investigator is the most likely cause for the stroke/TIA event. [Note: If a baseline echocardiogram cannot be obtained clinically after the index event and prior to study enrollment, then it is acceptable for study purposes for an echocardiogram to be obtained after patient enrollment into the study but prior to the 90-day follow-up visit. Alternatively, an echocardiogram already performed within one year prior to study enrollment may serve as the baseline echocardiogram for study purposes.]
- Age 55 years or older [Note: Participants aged 55-59 years should have imaging confirmation of the index stroke/TIA event with an embolic imaging pattern of acute cerebral ischemia]
- Informed consent from the patient (or from a legally authorized representative if the patient is not competent, e.g. due to stroke-related cognitive impairment, aphasia, or anosognosia).
- The patient is expected to survive at least 6 months.
The patient has a valid provincial health insurance number.
- The index event will be defined as the event leading to medical presentation
Exclusion:
- Any previously documented atrial fibrillation or atrial flutter, i.e. a past history of atrial fibrillation/flutter or atrial fibrillation/flutter detected on ECG, Holter, or telemetry following the index stroke/TIA event (a remote history of transient perioperative atrial fibrillation is not exclusionary
- Exclusively retinal stroke or TIA event.
- A most responsible etiological diagnosis for the qualifying stroke/TIA event has already been determined, i.e. probable small-vessel (lacunar) disease, probable large vessel disease, cervicocephalic artery dissection, venous sinus thrombosis, hypercoagulable states, or other known cause.
- Planned carotid endarterectomy within 90 days.
- Patient is already currently participating in a clinical trial involving an investigational medication or device.*
- Any finding on echocardiography for which there is already an evidence-based indication for long-term anticoagulation (e.g. mechanical heart valve, thrombus, etc.).
- Endocarditis
- Pacemaker or ICD device.
- Patients with known skin reactions to synthetic polymers or to silver. (Some people who display sensitivity to silver jewellery are sensitive to the impurities present in silver alloys and not to the silver itself. These people may participate.)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: repeat 24-hour Holter monitor
|
Repeat standard 24-hour Holter Monitor
Other Names:
|
Experimental: 30-day ambulatory cardiac event monitor
|
Patients will be fitted with dry electrode belt (including cardiac event monitor)and instructed to wear the device for as many hours(waking and sleeping) each day as possible, for a total of 30 days.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Detection of one or more episodes of atrial fibrillation or atrial flutter ≥30 seconds, as assessed at the 90 day follow-up
Time Frame: 90 days
|
90 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Atrial fibrillation <30 seconds
Time Frame: 90 days
|
90 days
|
Atrial flutter <30 seconds
Time Frame: 90 days
|
90 days
|
Non-sustained (>3 beats, <30 seconds) irregular atrial tachyarrhythmia (including brief runs of atrial fibrillation)
Time Frame: 90 days
|
90 days
|
Proportion of patients in each group that are prescribed oral anticoagulation, as assessed at the 90-day follow-up
Time Frame: 90 days
|
90 days
|
Patient adherence with 30-day monitoring: average proportion of days wearing the monitor per patient, and the percentage of patients wearing the monitor for >75% of the target period
Time Frame: 90 days
|
90 days
|
1 and 2-year recurrence of ischemic stroke/TIA, death, hemorrhagic stroke, major adverse bleeding event, detection of atrial fibrillation outside of the study protocol
Time Frame: 2 years
|
2 years
|
composite endpoint of: (1) AF >30 seconds, (2) non-sustained (>3 beats, <30 seconds) irregular atrial tachyarrhythmia (including brief runs of AF), or (3) atrial flutter.
Time Frame: 90 days
|
90 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: David J Gladstone, MD, PhD, FRCPC, Sunnybrook Health Sciences Centre
Publications and helpful links
General Publications
- Gladstone DJ, Dorian P, Spring M, Panzov V, Mamdani M, Healey JS, Thorpe KE; EMBRACE Steering Committee and Investigators. Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the EMBRACE trial. Stroke. 2015 Apr;46(4):936-41. doi: 10.1161/STROKEAHA.115.008714. Epub 2015 Feb 19.
- Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, Vaid H, O'Donnell M, Laupacis A, Cote R, Sharma M, Blakely JA, Shuaib A, Hachinski V, Coutts SB, Sahlas DJ, Teal P, Yip S, Spence JD, Buck B, Verreault S, Casaubon LK, Penn A, Selchen D, Jin A, Howse D, Mehdiratta M, Boyle K, Aviv R, Kapral MK, Mamdani M; EMBRACE Investigators and Coordinators. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014 Jun 26;370(26):2467-77. doi: 10.1056/NEJMoa1311376.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Embrace001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on 24-hour Holter
-
CMC Ambroise ParéNot yet recruiting
-
Sheffield Teaching Hospitals NHS Foundation TrustRecruitingColorectal Cancer | Atrial Fibrillation New OnsetUnited Kingdom
-
Medical University of GrazRecruitingAtrial Fibrillation | ICD | Pacemaker DddAustria
-
Sigknow Biomedical Co., Ltd.UnknownAtrial Fibrillation | Arrhythmias, CardiacTaiwan
-
Karolinska InstitutetDanderyd HospitalRecruitingAtrial Fibrillation | Atrial Flutter | Supraventricular Beat, Premature | Premature Supraventricular Beats | Premature Atrial Complex | Extrasystole, AtrialSweden
-
Children's National Research InstituteEnrolling by invitationSyncope | Cardiac ArrhythmiaUnited States
-
University Hospital, BordeauxGrant Agreement ERC n°715093; University of Bordeaux - mission UB-C19CompletedCOVID-19 | Virus DiseaseFrance
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingMyocardial Ischemia | Acute Coronary SyndromeItaly
-
Ewha Womans University Mokdong HospitalKorea Health Industry Development InstituteRecruitingIschemic Stroke | Atrial Fibrillation | Transient Ischemic AttackKorea, Republic of
-
Goztepe Training and Research HospitalCompletedType 2 Diabetes | Heart Rate VariabilityTurkey